CYTK240628C56000
- 0.50
- 0.000.00%
Cytokinetics Newsroom
Insider Sale: Director B Parshall Sells 5,000 Shares of Cytokinetics Inc (CYTK)
Cytokinetics(CYTK.US) Director Sells US$271.1K in Common Stock
Cytokinetics(CYTK.US) Officer Sells US$621.58K in Common Stock
Form 144 | Cytokinetics(CYTK.US) Director Proposes to Sell 271.09K in Common Stocks
SEC FILLINGS DISCLOSED/ Jul 1, $Cytokinetics(CYTK.US)$ Director B LYNNE PARSHALL intends to sell 5,000 shares of its common stock on Jul 1, with a total market value of approximately $271.09K. B LYN
Form 144 | Cytokinetics(CYTK.US) Officer Proposes to Sell 621.62K in Common Stocks
SEC FILLINGS DISCLOSED/ Jul 1, $Cytokinetics(CYTK.US)$ Officer ROBERT BLUM intends to sell 11,500 shares of its common stock on Jul 1, with a total market value of approximately $621.62K. ROBERT BLU
Unusual Options Activity: CTLT, STX and Others Attract Market Bets, CTLT V/OI Ratio Reaches 250.0
Cytokinetics(CYTK.US) Officer Sells US$392.14K in Common Stock
Form 144 | Cytokinetics(CYTK.US) Officer Proposes to Sell 392.17K in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 25, $Cytokinetics(CYTK.US)$ Officer FADY MALIK intends to sell 7,300 shares of its common stock on Jun 25, with a total market value of approximately $392.17K. FADY MALIK
Cytokinetics Is Maintained at Overweight by JP Morgan
J.P. Morgan Maintains Cytokinetics(CYTK.US) With Buy Rating, Announces Target Price $65
Express News | Cytokinetics Inc : JP Morgan Cuts Target Price to $65 From $77
Unusual Options Activity: DDOG, BABA and Others Attract Market Bets, DDOG V/OI Ratio Reaches 162.5
This Insider Has Just Sold Shares In Cytokinetics
Insider Selling: Director B Parshall Sells Shares of Cytokinetics Inc (CYTK)
Cytokinetics(CYTK.US) Director Sells US$262.75K in Common Stock
Cytokinetics(CYTK.US) Officer Sells US$1.18 Million in Common Stock
Form 144 | Cytokinetics(CYTK.US) Officer Proposes to Sell 1.18 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 17, $Cytokinetics(CYTK.US)$ Officer ROBERT BLUM intends to sell 22,500 shares of its common stock on Jun 17, with a total market value of approximately $1.18 million. ROB
Cytokinetics Insider Sold Shares Worth $1,183,391, According to a Recent SEC Filing
Form 144 | Cytokinetics(CYTK.US) Director Proposes to Sell 262.73K in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 17, $Cytokinetics(CYTK.US)$ Director B LYNNE PARSHALL intends to sell 5,000 shares of its common stock on Jun 17, with a total market value of approximately $262.73K. B L
H.C. Wainwright Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $90